Brian Leedman – Non-Executive Chairman – Neurotech is focused on facilitating the development and commercialisation of solutions for the screening and treatment of symptoms associated with neurological conditions such as autism.
Targeting autism with medicinal cannabinoids
Brian Leedman - Non-Executive Chairman - Neurotech is focused on facilitating the development and commercialisation of solutions for the screening and treatment of symptoms associated with neurological conditions such as autism.
- Published on August 9, 2021
- By Company News
Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X
Recent Posts
- ASX 200 Finishes Flat Amid Global PressuresNovember 12, 2026
- Schroders Australian Equity Fund Posts Strong YearNovember 12, 2026
- Global Tech Shake-Up Amidst Local Financial ScrutinyNovember 12, 2026
- Australian Shares Decline Amid Nvidia Leadership ReportsNovember 12, 2026
- Millennium Founder's Ruthless Trading RuleNovember 12, 2026
All Categories
- Battery Technology (2)
- Biotechnology (101)
- brekkie wrap (477)
- Broker News (2466)
- Commodities (1680)
- Hydrogen (6)
- Lithium (106)
- Potash (11)
- Rare Earths (6)
- Renewables (35)
- Company (7)
- Corporate Connect Research (24)
- Currencies (42)
- Cryptocurrencies (28)
- daily special (71)
- David Bassanese (90)
- Economics (3084)
- ESG (117)
- Etfs (500)
- EV Space (128)
- Featured (137)
- FinTech (26)
- Fixed Interest (231)
- FNN Content (6112)
- Franklin Templeton (1)
- fresh grind (4198)
- fundie guide (22)
- Funds (1422)
- Gavin Wendt (141)
- Greg Tolpigin (75)
- hot stocks (443)
- Infrastructure (28)
- Interest Rates (386)
- investor blend (65)
- IPOs (20)
- James Dunn (185)
- Kris Walesby (67)
- LICs (162)
- Marc Sinatra (4)
- market mocha (7823)
- Market Reports Text (283)
- Markets (14003)
- Media (71)
- Noosa Mining Conference (29)
- Podcasts (1)
- Politics (53)
- Product Profiles (23)
- Property (225)
- Reports (511)
- Retail (254)
- round table (8)
- Shane Oliver (260)
- Shares (18215)
- Stocks of the Hour (300)
- sip & learn (23)
- sip and learn (81)
- Sponsored Content (32)
- Strategy (204)
- Super (36)
- table for two (106)
- Technical Analysis (5)
- Technology (419)
- The Week that Was (112)
- Tim Boreham (85)
- Uncategorized (157)
- Video (4332)
- Webinars (195)
- Weekly Wrap (831)